Technical Analysis for PLXP - PLx Pharma Inc.

Grade Last Price % Change Price Change
grade A 4.88 12.18% 0.53
PLXP closed up 12.18 percent on Friday, January 18, 2019, on 1.99 times normal volume.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical PLXP trend table...

Date Alert Name Type % Chg
Jan 18 Pocket Pivot Bullish Swing Setup 0.00%
Jan 18 Parabolic Rise Strength 0.00%
Jan 18 Upper Bollinger Band Walk Strength 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Up 3 Days in a Row Strength 0.00%
Jan 18 Up 4 Days in a Row Strength 0.00%
Jan 18 Upper Bollinger Band Touch Strength 0.00%
Jan 17 Shooting Star Candlestick Bearish 12.18%
Jan 17 Lizard Bearish Bearish Day Trade Setup 12.18%
Jan 17 Pocket Pivot Bullish Swing Setup 12.18%

Older signals for PLXP ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:
Profile
PLx Pharma Inc., formerly Dipexium Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is a late stage specialty pharmaceutical company focusing on commercializing its lead products: Aspertec 325 mg and Aspertec 81 mg (Aspertec). The Company’s products and technology includes PLxGuard delivery system, Aspertec 325 mg, PL1100/PL1200 Ibuprofen. PLxGuard delivery system uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs to selectively release these drugs to targeted portions of the GI tract. The Company’s lead product Aspertec 325 mg is a liquid-fill aspirin capsule for prevention of cardiovascular disease. Through PLxGuard delivery system the Company creates a lipid-based formulation of ibuprofen, PL1200 Ibuprofen Capsules, 200 mg.
Is PLXP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jan 18 Midday movers and shakers
Jan 17 PLx Pharma adds to rally, up 26%
Jan 17 Lipocine leads healthcare gainers; CHF Solutions and Altimmune among losers
Jan 17 PLx Pharma's Capital Raise More Dilutive Than Expected, Raymond James Says
Jan 14 41 Stocks Moving In Monday's Mid-Day Session
Jan 14 Microbot Medical leads healthcare gainers; Verona Pharma and Prestige Consumer Healthcare among losers
Jan 10 Microcaps dominate midday movers
Jan 10 PLx Pharma up 26%
Jan 10 Amarin and Novan among healthcare gainers; Atossa Genetics and Axsome Therapeutics among losers
Jan 2 Prana Biotechnology leads healthcare gainers; MyoKardia and Cutera among losers
See more PLXP news...
Indicators
Indicator Value
52 Week High 7.6
52 Week Low 1.0
Average Volume 55,406
200-Day Moving Average 3.7873
50-Day Moving Average 3.4502
20-Day Moving Average 2.7928
10-Day Moving Average 3.883
Average True Range 0.693
ADX 40.76
+DI 40.7958
-DI 8.8578
Chandelier Exit (Long, 3 ATRs ) 4.151
Chandelier Exit (Short, 3 ATRs ) 3.079
Upper Bollinger Band 5.261
Lower Bollinger Band 0.3246
Percent B (%b) 0.92
BandWidth 176.754512
MACD Line 0.3841
MACD Signal Line 0.0892
MACD Histogram 0.2948
Fundamentals Value
Market Cap 42.4 Million
Num Shares 8.69 Million
EPS -1.03
Price-to-Earnings (P/E) Ratio -4.74
Price-to-Sales 196.43
Price-to-Book 5.02
PEG Ratio -0.13
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.56
Resistance 3 (R3) 6.52 5.92 6.28
Resistance 2 (R2) 5.92 5.49 5.94 6.19
Resistance 1 (R1) 5.40 5.23 5.66 5.44 6.09
Pivot Point 4.80 4.80 4.93 4.82 4.80
Support 1 (S1) 4.28 4.37 4.54 4.32 3.67
Support 2 (S2) 3.68 4.11 3.70 3.57
Support 3 (S3) 3.16 3.68 3.48
Support 4 (S4) 3.20